Johnson Chemical Pharmaceutical Works Co (ROCO:4747) 3-Year EBITDA Growth Rate : 6.90% (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Johnson Chemical Pharmaceutical Works Co 3-Year EBITDA Growth Rate?

Johnson Chemical Pharmaceutical Works Co's EBITDA per Share for the three months ended in Mar. 2024 was NT$0.69.

During the past 12 months, Johnson Chemical Pharmaceutical Works Co's average EBITDA Per Share Growth Rate was -9.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 6.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 4.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -0.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Johnson Chemical Pharmaceutical Works Co was 38.20% per year. The lowest was -10.60% per year. And the median was 3.30% per year.

Competitive Comparison of Johnson Chemical Pharmaceutical Works Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Johnson Chemical Pharmaceutical Works Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Johnson Chemical Pharmaceutical Works Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson Chemical Pharmaceutical Works Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Johnson Chemical Pharmaceutical Works Co's 3-Year EBITDA Growth Rate falls into.

Johnson Chemical Pharmaceutical Works Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Johnson Chemical Pharmaceutical Works Co (ROCO:4747) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Johnson Chemical Pharmaceutical Works Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Johnson Chemical Pharmaceutical Works Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Johnson Chemical Pharmaceutical Works Co (ROCO:4747) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson Chemical Pharmaceutical Works Co (ROCO:4747) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sanhe Road, No. 77 and No. 79, Section 4, Sanchong District, New Taipei, TWN, 241

Website

http://www.jcpjohnson.com.tw

Johnson Chemical Pharmaceutical Works Co is engaged in the manufacturing of pharmaceutical ingredients importing and selling pharmaceutical materials and products. It manufactures drugs in a variety of forms, including solid dosage forms, capsules (soft/hard), tablets (sugar/film-coated), powder and granule, as well as nasal sprays. It offers products in therapeutic areas including the central nervous system, respiratory, cardiovascular, gastrointestinal, and endocrine system, vitamins, anti-inflammatory, cough and cold, and pain relievers. It organization's revenue mainly comes from medical product sales.

Johnson Chemical Pharmaceutical Works Co (ROCO:4747) Headlines

No Headlines